Planning for Medicare Premiums and Drug Costs Is a Difficult Fact of Life

A new EBRI analysis suggests some couples retiring in the near future could need as much as $370,000 in dedicated savings just for medical care; small wonder to see workers are hungry for advice on managing Medicare premiums and drug costs.

The Employee Benefits Research Institute (EBRI) published a new EBRI Notes report on the topic of ballooning retiree medical care costs.

Researchers examine the amount of savings couples will require to cover common medical costs accrued later in life. In particular, premiums for Medicare Parts B and D, premiums for Medigap Plan F, and out-of-pocket spending for outpatient prescription drugs are weighed. Taking all of these costs together, the EBRI analysis comes to an eye-popping sum.

Want the latest retirement plan adviser news and insights? Sign up for PLANADVISER newsletters.

“In 2017, a 65-year-old man needs $73,000 in savings and a 65-year-old woman needs $95,000 if each have a goal of having a 50% chance of having enough savings to cover premiums and median prescription drug expenses in retirement,” the analysis states. “If they want a 90% chance of having enough savings, the man needs $131,000 and the woman needs $147,000.”

According to EBRI, a couple with median prescription drug expenses needs $169,000 if they have a goal of having a 50% chance of having enough savings to cover health care expenses in retirement. If the couple wants a 90% chance of having enough savings, they need $273,000.

“For a couple with drug expenses at the 90th percentile throughout retirement who want a 90% chance of having enough money saved for health care expenses in retirement by age 65, targeted savings is $368,000 in 2017,” EBRI says. “From 2016 to 2017, projected savings targets increased between 1% and 6%. In contrast, savings targets declined between 2011 and 2014, but then increased from 2014 to 2016 as well.”

Despite the increase in savings targets since 2014, EBRI finds the 2017 savings targets continue to be lower than they were in 2012 almost across the board.

Where the costs come from

The EBRI analysis goes into some depth in explaining how these large sums add up so quickly. Important to the outcome is that the study assumes that all individuals and couples have Medigap Plan F coverage in retirement, and “thus treats all individuals and couples as having the Plan F premium as an expense,  because this approach takes away the uncertainty related to actual use of specific health care services over one’s lifetime.”

“That is, instead of trying to predict when a Medicare beneficiary may use health care services and thus incur health expenses, which are highly dependent on whether the individual has reached their Medicare Part A and/or Part B deductibles, this study assumes that beneficiaries have the most comprehensive health insurance coverage available that is supplemental to Medicare (i.e., Plan F) and thus pay premiums for this coverage on a regular basis,” EBRI explains.

This study includes estimates on out-of-pocket spending for prescription drugs based on data from the Medical Expenditure Panel Survey (MEPS). EBRI researchers highlight that it is currently possible for new Medicare beneficiaries to purchase Medigap insurance (e.g., Plan F) to completely avoid deductibles and other cost sharing associated with Medicare Parts A and B; but it is not possible to avoid the deductibles and other cost sharing associated with Part D outpatient prescription drugs. “Thus, under Part D, for expenses above the deductible, beneficiaries are responsible for 25% coinsurance on expenses between the deductible and the initial benefit limit. And once the initial benefit limit is reached, beneficiaries are in the donut hole until they reach the catastrophic limit, above which they pay 5% coinsurance. When outpatient prescription drug coverage was added to Medicare in 2006, beneficiaries in the donut hole paid 100 % coinsurance. When ACA was enacted, it included a provision to phase in a reduction in the donut hole to 25 percent coinsurance by 2020.”

The research concludes in no uncertain terms that individuals should be concerned about saving for health insurance premiums and out-of-pocket expenses in retirement. 

“Medicare generally covers only about two-thirds of the cost of health care services for Medicare beneficiaries ages 65 and older, while out-of-pocket spending accounts for 12%,” EBRI states. “Furthermore, the percentage of private-sector establishments offering retiree health benefits has been falling. This is also true in the public sector.”

Read the full report here.

Investment Products and Services Launches

BNY Mellon releases fund focused on income generation, and AI Insight announces new liquid alternative research.

BNY Mellon Investment Management has announced the recent launch of Dreyfus Global Multi-Asset Income Fund, which began offering its shares on November 30, 2017. The fund uses an actively managed global multi-asset strategy that focuses on income generation.

BNY Mellon’s Dreyfus Corporation serves as the investment adviser of the fund, and Newton Investment Management (North America) Limited serves as the fund’s sub-investment adviser. Paul Flood and Bhavin Shah are the fund’s primary portfolio managers. Flood, the fund’s lead portfolio manager, is the lead manager of Newton’s global multi-asset income and multi-asset diversified return strategies. He joined Newton in 2006. Shah is an investment manager on the multi-asset team at Newton, and joined in June 2011.

Never miss a story — sign up for PLANADVISER newsletters to keep up on the latest retirement plan adviser news.

“With the launch of Dreyfus Global Multi-Asset Income Fund, we see the potential for U.S. investors to capture attractive income streams globally, while diversifying risk through Newton’s multi-asset, active approach,” says Joe Moran, head of distribution, The Dreyfus Corporation, A BNY Mellon company. “Across the investment landscape we are seeing a shift away from one asset class products focused on a single region in favor of products that invest across the full spectrum of asset classes, and we are responding to that demand with what we believe are our ‘best-in-breed’ boutique offerings.”

Newton allocates the fund’s investments across asset classes seeking to construct a diversified portfolio focused on income generation, while maintaining the potential for long-term capital appreciation and managing the risk profile of the fund’s portfolio of investments. Newton allocates the fund’s investments among equity and equity-related securities, debt and debt-related securities, and, generally to a lesser extent, real estate, commodities and infrastructure in developed and emerging markets. The fund seeks to gain exposure to various asset classes principally through direct investments in securities, but the fund also may use derivative instruments and investments in other investment companies, including exchange-traded funds, and real estate investment trusts for such exposure.

“Investors need investment options that can deliver not only a current income stream, but that take a long-term approach to capital appreciation. We see Dreyfus Global Multi-Asset Income Fund, which aims to provide current income while maintaining the potential for long-term capital appreciation, as an opportunity that can provide for both needs,” says Flood. “The Fund draws upon Newton’s strong heritage of managing multi-asset portfolios, deep experience across global markets and rigorous fundamental analysis to unearth our highest-conviction ideas for investors.”

The fund offers Class A (DRAAX), Class C (DRACX), and Class I (DRAIX) shares with a minimum initial investment of $1,000. The fund also offers Class Y (DRAYX) shares generally with a minimum initial investment of $1,000,000.  Additional information regarding the fund can be found on Dreyfus’ website at www.dreyfus.com.

AI Insight Announces New Liquid Alternative Research

AI Insight Inc. will begin offering liquid alternative research reports in 2018, enabling advisers to compare the details and financial performance of alternative investment mutual funds.

Given the growing popularity of liquid alternatives and need for research around this asset class, the reports are designed to provide financial professionals with the information they need to understand the complexities of these investments, while making it easy for them to document for regulatory compliance.

AI Insight also announced the release of a whitepaper, Understanding the Complexities of Liquid Alternatives, which provides information around liquid alternatives, including regulators’ guidance and definition of liquid alternatives; different types of funds; supervision; and training and documentation recommendations.  

AI Insight wrote the whitepaper in response to regulators’ increased focus on liquid alternatives, including the release of a Financial Industry Regulatory Authority (FINRA) e-learning course, Understanding Alternative Mutual Funds in August 2017 and a recently reissued Investor Alert by FINRA and the Securities and Exchange Commission (SEC), Alternative Funds Are Not Your Typical Mutual Funds.

In addition to making the Understanding Alternative Mutual Funds FINRA e-learning course available on its platform, AI Insight currently offers over 80 CE courses eligible for .5 to 2 credits toward the CFP and other designations, as well as prospectus- and PPM-based research and training.

To support its liquid alternative research capabilities, AI Insight has hired Lucas Johnson, CFA, to help lead the initiative. Johnson was formerly a due diligence analyst with National Planning Holdings, Inc., where he specialized in due diligence reviews of liquid alternatives and other alternative investments.   

“We are excited to welcome Lucas to the team to help expand our liquid alternative research capabilities,” says Sherri Cooke, president and chief executive officer of AI Insight. “AI Insight is dedicated to providing advisers with the tools and resources they need to understand the risks, rewards and investment strategies of complex products.”  

More information on AI Insight’s e-learning catalog can be found here.

«